OLUMIANT
207924 | Orange Book
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Patent | Expiration |
---|---|
8,420,629 | 4 years, 1 month from now |
8,158,616 | 5 years, 4 months from now |
11,045,474 | 7 years, 10 months from now |
9,089,574 | 7 years, 10 months from now |
Date | Patent / Filing No. | Patent and Drug Application Information |
---|---|---|
11/30/2032 | 9089574 | Expiration of Patent No 9,089,574: (U-3372). |
11/30/2032 | 11045474 | Expiration of Patent No 11,045,474: (U-3372). |
6/8/2030 | 8158616 | Expiration of Patent No 8,158,616: (drug product) |
3/10/2029 | 8420629 | Expiration of Patent No 8,420,629: (U-247). |
6/13/2022 | SUPPL-7 | Efficacy-New Indication: |
5/10/2022 | Approval for OLUMIANT, 4MG
| |
5/10/2022 | SUPPL-6 | Efficacy-New Indication: |
12/2/2021 | SUPPL-4 | Labeling-Medication Guide, Labeling-Package Insert: |
7/8/2020 | SUPPL-2 | Labeling-Package Insert: |
10/8/2019 | Approval for OLUMIANT, 1MG
| |
10/8/2019 | SUPPL-1 | Efficacy-New Dosing Regimen: |
5/31/2018 | Approval for OLUMIANT, 2MG
| |
5/31/2018 | ORIG-1 | Approval:
|